Inventor
FASS GENE TIMOTHY
US8 patents
⚠️ This page may combine multiple inventors who share the name “FASS GENE TIMOTHY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
THERAVANCE BIOPHARMA R&D IP LLC
7 patentsUS10844057B2Nov 24, 2020
Process for preparing JAK inhibitors and intermediates thereof
THERAVANCE BIOPHARMA R&D IP LLC11 citations84
US11702415B2Jul 18, 2023
Crystalline hydrate of a JAK inhibitor compound
THERAVANCE BIOPHARMA R&D IP LLC6 citations83
US10752599B2Aug 25, 2020
Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof
THERAVANCE BIOPHARMA R&D IP LLC3 citations82
US10100021B2Oct 16, 2018
Crystalline(2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof
THERAVANCE BIOPHARMA R&D IP LLC4 citations82
US11718591B2Aug 8, 2023
Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2- methylpentanoic acid and uses thereof
THERAVANCE BIOPHARMA R&D IP LLC1 citations70
US11718616B2Aug 8, 2023
JAK kinase inhibitor compounds for treatment of respiratory disease
THERAVANCE BIOPHARMA R&D IP LLC0 citations62
US12122773B2Oct 22, 2024
Crystalline hydrate of a JAK inhibitor compound
THERAVANCE BIOPHARMA R&D IP LLC0 citations60